Edit |   |
---|---|
Product Name | Ruxilitinib |
Description | Ruxilitinib is a small molecule which can act as a JAK inhibitor. It is provided as a powder. This product acts on the following target types: Kinase. This product acts on the following biochemical pathways: Cytokine, Proliferation, JAK/STAT. This product may be of interest in the following research areas and diseases: Inflammation, Cancer. This product may act as a Coronavirus inhibitor: Inhibits MARK2/3, which interact with SARS-CoV-2 Orf9b. Please note that our chemical products are for scientific research use only and are not for medical or veterinary use. This product can only be dispatched to a scientific business or laboratory address. MW: 306.37 g/mol |
Size | 5 mg, 25 mg |
Concentration | n/a |
Applications | n/a |
Other Names | Ruxolitinib, βR-Cyclopentyl-4-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-1H-pyrazole-1-propanenitrile, INCB 018424, 941678-49-5 |
Gene, Accession, CAS # | CAS: 941678-49-5 |
Catalog # | abx076799 |
Price | please inquire |
Order / More Info | Ruxilitinib from ABBEXA LTD |
Product Specific References | n/a |
U.S. Office
118 Eldridge Rd, Suite C,
Sugar Land, TX 77478 USA
Telephone: +1 832 327 7413
Netherlands Office
Abbexa BV
Wattstraat 54 2723 RD,
Zoetermeer,Netherlands
Telephone: +44 (0) 1223 755950